Focus on the cutting edge, dedicated to protection.
Stay tuned for the latest updates from BIOALLY.
2026-07-13
Bolaideli: Reimagining China’s Pet Biopharmaceutical Landscape Through Original-Research Innovation
From the world’s first Boshengjian® canine serum albumin injection to the Miao Beihu® feline trivalent vaccine, which has surpassed 5.5 million doses in total batch releases just 2.5 years after launch, and to a portfolio of pioneering biologics currently under development, Taizhou Bolaideli Biotechnology Co., Ltd. (hereinafter referred to as Bolaideli) has forged an original‑innovation path—“from zero to one”—for Chinese pet‑pharmaceutical companies.
Learn more
